Instituto de Oncología Ángel H. Roffo - CABA, Buenos Aires

Instituto de Oncología Ángel H. Roffo - CABA, Buenos Aires
Av. San Martín 5481, CABA, Buenos Aires
Select an option

Our team

Medical staff
Eduardo Gonzalez
Viviana Cuartero
Valeria Cáceres
Florencia Guerra

Open studies

Breast Cancer
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) - PionERA - Hoffmann-La RocheSee more
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) - MK-2870-012 - Merck Sharp & Dohme LLCSee more
Lung cancer
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) - ABBV-399 - AbbVieSee more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy